Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding
To assess morbidity and mortality of parainfluenza virus (PIV) infections in immunocompromised patients, we analysed PIV infections in a hematology and stem cell transplantation (SCT) unit over the course of three years. Isolated PIV strains were characterized by sequence analysis and nosocomial tra...
Gespeichert in:
Veröffentlicht in: | PloS one 2022-07, Vol.17 (7), p.e0271756-e0271756 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0271756 |
---|---|
container_issue | 7 |
container_start_page | e0271756 |
container_title | PloS one |
container_volume | 17 |
creator | Tabatabai, Julia Schnitzler, Paul Prifert, Christiane Schiller, Martin Weissbrich, Benedikt von Lilienfeld-Toal, Marie Teschner, Daniel Jordan, Karin Müller-Tidow, Carsten Egerer, Gerlinde Giesen, Nicola |
description | To assess morbidity and mortality of parainfluenza virus (PIV) infections in immunocompromised patients, we analysed PIV infections in a hematology and stem cell transplantation (SCT) unit over the course of three years. Isolated PIV strains were characterized by sequence analysis and nosocomial transmission was assessed including phylogenetic analysis of viral strains. 109 cases of PIV infection were identified, 75 in the setting of SCT. PIV type 3 (n = 68) was the most frequent subtype. PIV lower respiratory tract infection (LRTI) was observed in 47 patients (43%) with a mortality of 19%. Severe leukopenia, prior steroid therapy and presence of co-infections were significant risk factors for development of PIV-LRTI in multivariate analysis. Prolonged viral shedding was frequently observed with a median duration of 14 days and up to 79 days, especially in patients after allogeneic SCT and with LRTI. Nosocomial transmission occurred in 47 patients. Phylogenetic analysis of isolated PIV strains and combination with clinical data enabled the identification of seven separate clusters of nosocomial transmission. In conclusion, we observed significant morbidity and mortality of PIV infection in hematology and transplant patients. The clinical impact of co-infections, the possibility of long-term viral shedding and frequent nosocomial transmission should be taken into account when designing infection control strategies. |
doi_str_mv | 10.1371/journal.pone.0271756 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2696472827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A711930502</galeid><doaj_id>oai_doaj_org_article_55dc4e1ed7874c6282ab9145dd7ba2be</doaj_id><sourcerecordid>A711930502</sourcerecordid><originalsourceid>FETCH-LOGICAL-c669t-89b70a7343ca99d5c0b786c058870643ad80a48d9ac36febe847d40442822fb3</originalsourceid><addsrcrecordid>eNqNk21r1TAUx4sobk6_gWBAEAXvNW3apPWFMIYPg8FEh2_DaZK2GWlyl6TT-c38dqb3VtmVvbB90fT0d_7noedk2dMcr3PC8jeXbvIWzHrjrFrjguWsoveyw7whxYoWmNy_dT7IHoVwiXFFakofZgekanCFWX6Y_foMHrTtzKTsT0DX2k8BpXclonZ2PqINRK1sDOi7jgMa1AjRGddrAQaNYHRvwQqtAnIehahGJJQxKHqwYWPARpiV3qLjlOxN0AnrkDDabv3FkMKLqLwOUYvwGlkXnHCjhkVh1CEkdwRWzsklcxiUlNr2j7MHHZignizPo-ziw_uLk0-rs_OPpyfHZytBaRNXddMyDIyUREDTyErgltVU4KquGaYlAVljKGvZgCC0U62qSyZLXJZFXRRdS46yZzvZjXGBL00PvKANLVliWCJOd4R0cMk3Xo_gb7gDzbcG53sOPlVnFK8qKUqVK8lqVgqa3KFt8rKSkrVQtCppvVuiTe2opEh9TzXvie5_sXrgvbvmDSGMVnMyLxcB764mFSJPHZx_CFjlpl3edSo7XUfZ83_Qu6tbqB5SAWkyXIorZlF-zPI0YWmQikSt76DSLdWoRZrQTif7nsOrPYfERPUj9jCFwE-_fvl_9vzbPvviFjsoMHEIzkzbad4Hyx0ovAvBq-5vk3PM5wX70w0-LxhfFoz8BpD4HDw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2696472827</pqid></control><display><type>article</type><title>Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Tabatabai, Julia ; Schnitzler, Paul ; Prifert, Christiane ; Schiller, Martin ; Weissbrich, Benedikt ; von Lilienfeld-Toal, Marie ; Teschner, Daniel ; Jordan, Karin ; Müller-Tidow, Carsten ; Egerer, Gerlinde ; Giesen, Nicola</creator><creatorcontrib>Tabatabai, Julia ; Schnitzler, Paul ; Prifert, Christiane ; Schiller, Martin ; Weissbrich, Benedikt ; von Lilienfeld-Toal, Marie ; Teschner, Daniel ; Jordan, Karin ; Müller-Tidow, Carsten ; Egerer, Gerlinde ; Giesen, Nicola</creatorcontrib><description>To assess morbidity and mortality of parainfluenza virus (PIV) infections in immunocompromised patients, we analysed PIV infections in a hematology and stem cell transplantation (SCT) unit over the course of three years. Isolated PIV strains were characterized by sequence analysis and nosocomial transmission was assessed including phylogenetic analysis of viral strains. 109 cases of PIV infection were identified, 75 in the setting of SCT. PIV type 3 (n = 68) was the most frequent subtype. PIV lower respiratory tract infection (LRTI) was observed in 47 patients (43%) with a mortality of 19%. Severe leukopenia, prior steroid therapy and presence of co-infections were significant risk factors for development of PIV-LRTI in multivariate analysis. Prolonged viral shedding was frequently observed with a median duration of 14 days and up to 79 days, especially in patients after allogeneic SCT and with LRTI. Nosocomial transmission occurred in 47 patients. Phylogenetic analysis of isolated PIV strains and combination with clinical data enabled the identification of seven separate clusters of nosocomial transmission. In conclusion, we observed significant morbidity and mortality of PIV infection in hematology and transplant patients. The clinical impact of co-infections, the possibility of long-term viral shedding and frequent nosocomial transmission should be taken into account when designing infection control strategies.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0271756</identifier><identifier>PMID: 35905071</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Analysis ; Biology and Life Sciences ; Blood diseases ; Computer and Information Sciences ; Coronaviruses ; Diagnosis ; Disease transmission ; Distribution ; Health risks ; Hematology ; Hospitals ; Immunocompromised hosts ; Infections ; Influenza ; Leukopenia ; Medicine and Health Sciences ; Morbidity ; Mortality ; Multivariate analysis ; Nosocomial infection ; Parainfluenza ; Patients ; Phylogenetics ; Phylogeny ; Proteins ; Respiratory syncytial virus ; Respiratory tract ; Respiratory tract diseases ; Risk analysis ; Risk factors ; Sequence analysis ; Severe acute respiratory syndrome coronavirus 2 ; Stem cell transplantation ; Stem cells ; Steroids ; Strains (organisms) ; Transplantation ; Viruses</subject><ispartof>PloS one, 2022-07, Vol.17 (7), p.e0271756-e0271756</ispartof><rights>COPYRIGHT 2022 Public Library of Science</rights><rights>2022 Tabatabai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Tabatabai et al 2022 Tabatabai et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c669t-89b70a7343ca99d5c0b786c058870643ad80a48d9ac36febe847d40442822fb3</citedby><cites>FETCH-LOGICAL-c669t-89b70a7343ca99d5c0b786c058870643ad80a48d9ac36febe847d40442822fb3</cites><orcidid>0000-0001-7351-8060 ; 0000-0003-3205-9464 ; 0000-0001-7791-8045</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337657/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337657/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79569,79570</link.rule.ids></links><search><creatorcontrib>Tabatabai, Julia</creatorcontrib><creatorcontrib>Schnitzler, Paul</creatorcontrib><creatorcontrib>Prifert, Christiane</creatorcontrib><creatorcontrib>Schiller, Martin</creatorcontrib><creatorcontrib>Weissbrich, Benedikt</creatorcontrib><creatorcontrib>von Lilienfeld-Toal, Marie</creatorcontrib><creatorcontrib>Teschner, Daniel</creatorcontrib><creatorcontrib>Jordan, Karin</creatorcontrib><creatorcontrib>Müller-Tidow, Carsten</creatorcontrib><creatorcontrib>Egerer, Gerlinde</creatorcontrib><creatorcontrib>Giesen, Nicola</creatorcontrib><title>Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding</title><title>PloS one</title><description>To assess morbidity and mortality of parainfluenza virus (PIV) infections in immunocompromised patients, we analysed PIV infections in a hematology and stem cell transplantation (SCT) unit over the course of three years. Isolated PIV strains were characterized by sequence analysis and nosocomial transmission was assessed including phylogenetic analysis of viral strains. 109 cases of PIV infection were identified, 75 in the setting of SCT. PIV type 3 (n = 68) was the most frequent subtype. PIV lower respiratory tract infection (LRTI) was observed in 47 patients (43%) with a mortality of 19%. Severe leukopenia, prior steroid therapy and presence of co-infections were significant risk factors for development of PIV-LRTI in multivariate analysis. Prolonged viral shedding was frequently observed with a median duration of 14 days and up to 79 days, especially in patients after allogeneic SCT and with LRTI. Nosocomial transmission occurred in 47 patients. Phylogenetic analysis of isolated PIV strains and combination with clinical data enabled the identification of seven separate clusters of nosocomial transmission. In conclusion, we observed significant morbidity and mortality of PIV infection in hematology and transplant patients. The clinical impact of co-infections, the possibility of long-term viral shedding and frequent nosocomial transmission should be taken into account when designing infection control strategies.</description><subject>Analysis</subject><subject>Biology and Life Sciences</subject><subject>Blood diseases</subject><subject>Computer and Information Sciences</subject><subject>Coronaviruses</subject><subject>Diagnosis</subject><subject>Disease transmission</subject><subject>Distribution</subject><subject>Health risks</subject><subject>Hematology</subject><subject>Hospitals</subject><subject>Immunocompromised hosts</subject><subject>Infections</subject><subject>Influenza</subject><subject>Leukopenia</subject><subject>Medicine and Health Sciences</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Multivariate analysis</subject><subject>Nosocomial infection</subject><subject>Parainfluenza</subject><subject>Patients</subject><subject>Phylogenetics</subject><subject>Phylogeny</subject><subject>Proteins</subject><subject>Respiratory syncytial virus</subject><subject>Respiratory tract</subject><subject>Respiratory tract diseases</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Sequence analysis</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Steroids</subject><subject>Strains (organisms)</subject><subject>Transplantation</subject><subject>Viruses</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk21r1TAUx4sobk6_gWBAEAXvNW3apPWFMIYPg8FEh2_DaZK2GWlyl6TT-c38dqb3VtmVvbB90fT0d_7noedk2dMcr3PC8jeXbvIWzHrjrFrjguWsoveyw7whxYoWmNy_dT7IHoVwiXFFakofZgekanCFWX6Y_foMHrTtzKTsT0DX2k8BpXclonZ2PqINRK1sDOi7jgMa1AjRGddrAQaNYHRvwQqtAnIehahGJJQxKHqwYWPARpiV3qLjlOxN0AnrkDDabv3FkMKLqLwOUYvwGlkXnHCjhkVh1CEkdwRWzsklcxiUlNr2j7MHHZignizPo-ziw_uLk0-rs_OPpyfHZytBaRNXddMyDIyUREDTyErgltVU4KquGaYlAVljKGvZgCC0U62qSyZLXJZFXRRdS46yZzvZjXGBL00PvKANLVliWCJOd4R0cMk3Xo_gb7gDzbcG53sOPlVnFK8qKUqVK8lqVgqa3KFt8rKSkrVQtCppvVuiTe2opEh9TzXvie5_sXrgvbvmDSGMVnMyLxcB764mFSJPHZx_CFjlpl3edSo7XUfZ83_Qu6tbqB5SAWkyXIorZlF-zPI0YWmQikSt76DSLdWoRZrQTif7nsOrPYfERPUj9jCFwE-_fvl_9vzbPvviFjsoMHEIzkzbad4Hyx0ovAvBq-5vk3PM5wX70w0-LxhfFoz8BpD4HDw</recordid><startdate>20220729</startdate><enddate>20220729</enddate><creator>Tabatabai, Julia</creator><creator>Schnitzler, Paul</creator><creator>Prifert, Christiane</creator><creator>Schiller, Martin</creator><creator>Weissbrich, Benedikt</creator><creator>von Lilienfeld-Toal, Marie</creator><creator>Teschner, Daniel</creator><creator>Jordan, Karin</creator><creator>Müller-Tidow, Carsten</creator><creator>Egerer, Gerlinde</creator><creator>Giesen, Nicola</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7351-8060</orcidid><orcidid>https://orcid.org/0000-0003-3205-9464</orcidid><orcidid>https://orcid.org/0000-0001-7791-8045</orcidid></search><sort><creationdate>20220729</creationdate><title>Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding</title><author>Tabatabai, Julia ; Schnitzler, Paul ; Prifert, Christiane ; Schiller, Martin ; Weissbrich, Benedikt ; von Lilienfeld-Toal, Marie ; Teschner, Daniel ; Jordan, Karin ; Müller-Tidow, Carsten ; Egerer, Gerlinde ; Giesen, Nicola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c669t-89b70a7343ca99d5c0b786c058870643ad80a48d9ac36febe847d40442822fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analysis</topic><topic>Biology and Life Sciences</topic><topic>Blood diseases</topic><topic>Computer and Information Sciences</topic><topic>Coronaviruses</topic><topic>Diagnosis</topic><topic>Disease transmission</topic><topic>Distribution</topic><topic>Health risks</topic><topic>Hematology</topic><topic>Hospitals</topic><topic>Immunocompromised hosts</topic><topic>Infections</topic><topic>Influenza</topic><topic>Leukopenia</topic><topic>Medicine and Health Sciences</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Multivariate analysis</topic><topic>Nosocomial infection</topic><topic>Parainfluenza</topic><topic>Patients</topic><topic>Phylogenetics</topic><topic>Phylogeny</topic><topic>Proteins</topic><topic>Respiratory syncytial virus</topic><topic>Respiratory tract</topic><topic>Respiratory tract diseases</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Sequence analysis</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Steroids</topic><topic>Strains (organisms)</topic><topic>Transplantation</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tabatabai, Julia</creatorcontrib><creatorcontrib>Schnitzler, Paul</creatorcontrib><creatorcontrib>Prifert, Christiane</creatorcontrib><creatorcontrib>Schiller, Martin</creatorcontrib><creatorcontrib>Weissbrich, Benedikt</creatorcontrib><creatorcontrib>von Lilienfeld-Toal, Marie</creatorcontrib><creatorcontrib>Teschner, Daniel</creatorcontrib><creatorcontrib>Jordan, Karin</creatorcontrib><creatorcontrib>Müller-Tidow, Carsten</creatorcontrib><creatorcontrib>Egerer, Gerlinde</creatorcontrib><creatorcontrib>Giesen, Nicola</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tabatabai, Julia</au><au>Schnitzler, Paul</au><au>Prifert, Christiane</au><au>Schiller, Martin</au><au>Weissbrich, Benedikt</au><au>von Lilienfeld-Toal, Marie</au><au>Teschner, Daniel</au><au>Jordan, Karin</au><au>Müller-Tidow, Carsten</au><au>Egerer, Gerlinde</au><au>Giesen, Nicola</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding</atitle><jtitle>PloS one</jtitle><date>2022-07-29</date><risdate>2022</risdate><volume>17</volume><issue>7</issue><spage>e0271756</spage><epage>e0271756</epage><pages>e0271756-e0271756</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>To assess morbidity and mortality of parainfluenza virus (PIV) infections in immunocompromised patients, we analysed PIV infections in a hematology and stem cell transplantation (SCT) unit over the course of three years. Isolated PIV strains were characterized by sequence analysis and nosocomial transmission was assessed including phylogenetic analysis of viral strains. 109 cases of PIV infection were identified, 75 in the setting of SCT. PIV type 3 (n = 68) was the most frequent subtype. PIV lower respiratory tract infection (LRTI) was observed in 47 patients (43%) with a mortality of 19%. Severe leukopenia, prior steroid therapy and presence of co-infections were significant risk factors for development of PIV-LRTI in multivariate analysis. Prolonged viral shedding was frequently observed with a median duration of 14 days and up to 79 days, especially in patients after allogeneic SCT and with LRTI. Nosocomial transmission occurred in 47 patients. Phylogenetic analysis of isolated PIV strains and combination with clinical data enabled the identification of seven separate clusters of nosocomial transmission. In conclusion, we observed significant morbidity and mortality of PIV infection in hematology and transplant patients. The clinical impact of co-infections, the possibility of long-term viral shedding and frequent nosocomial transmission should be taken into account when designing infection control strategies.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>35905071</pmid><doi>10.1371/journal.pone.0271756</doi><tpages>e0271756</tpages><orcidid>https://orcid.org/0000-0001-7351-8060</orcidid><orcidid>https://orcid.org/0000-0003-3205-9464</orcidid><orcidid>https://orcid.org/0000-0001-7791-8045</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2022-07, Vol.17 (7), p.e0271756-e0271756 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2696472827 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
subjects | Analysis Biology and Life Sciences Blood diseases Computer and Information Sciences Coronaviruses Diagnosis Disease transmission Distribution Health risks Hematology Hospitals Immunocompromised hosts Infections Influenza Leukopenia Medicine and Health Sciences Morbidity Mortality Multivariate analysis Nosocomial infection Parainfluenza Patients Phylogenetics Phylogeny Proteins Respiratory syncytial virus Respiratory tract Respiratory tract diseases Risk analysis Risk factors Sequence analysis Severe acute respiratory syndrome coronavirus 2 Stem cell transplantation Stem cells Steroids Strains (organisms) Transplantation Viruses |
title | Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T01%3A37%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parainfluenza%20virus%20infections%20in%20patients%20with%20hematological%20malignancies%20or%20stem%20cell%20transplantation:%20Analysis%20of%20clinical%20characteristics,%20nosocomial%20transmission%20and%20viral%20shedding&rft.jtitle=PloS%20one&rft.au=Tabatabai,%20Julia&rft.date=2022-07-29&rft.volume=17&rft.issue=7&rft.spage=e0271756&rft.epage=e0271756&rft.pages=e0271756-e0271756&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0271756&rft_dat=%3Cgale_plos_%3EA711930502%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2696472827&rft_id=info:pmid/35905071&rft_galeid=A711930502&rft_doaj_id=oai_doaj_org_article_55dc4e1ed7874c6282ab9145dd7ba2be&rfr_iscdi=true |